09885 YSB
- 6.290
- +0.080+1.29%
YSB News
ysb (09885) issued 31.6786 million shares on November 26th.
Ysb (09885) issued an announcement that, according to the share purchase agreement, will operate under general authorization on November 26, 2024...
ysb (09885.HK) granted 1.86 million shares of bonus shares.
On November 6, Gronghui announced that ysb (09885.HK) issued 1.86 million bonus shares to the grantees under the stock incentive plan in 2024, accounting for approximately 0.29% of the total number of issued shares as of the date of this announcement. The reason for granting the bonus is to provide incentives for the grantees to strive for the success of the company and its affiliates, reward their unremitting efforts, and provide a way for them to benefit from the appreciation of shares by granting bonus shares.
YSB Set to Acquire Folding Space (Cayman) for 1.03 Billion Yuan, Changes Use of Proceeds From Global Offering
HK stocks surge | ysb (09885) opens over 5% higher, planning to acquire a pharmaceutical block with issued and outstanding shares totaling 1.035 billion yuan 100%
YSB (09885) opened more than 5% higher, as of the time of publication, it rose by 5.43%, closing at 7.76 Hong Kong dollars, with a turnover of 0.4982 million Hong Kong dollars.
YSB (09885) completed a full acquisition of a pharmaceutical company for 1.035 billion, accelerating the layout of its own brand business.
On October 15, 2024, YSB (09885) announced on the HKEX website that it has signed a trading agreement to acquire 100% equity of csi health care 100 index. The total consideration for the acquisition is RMB 1.035 billion, with a cash consideration of RMB 0.42 billion, and a stock consideration of RMB 0.615 billion.
YSB (09885.HK) cash plus new shares fully subscribed Hunan space folding, involving more than 1 billion RMB.
YSB (09885.HK) announced the acquisition of 100% equity of Hunan Spatial Fold, an independent third party, to acquire pharmaceutical supply chain, operation service platform, and related businesses. Through merging two customer networks, it aims to achieve mutual penetration and complementary advantages. The total consideration is 1.035 billion RMB, including 0.42 billion RMB in cash; and up to 56.2918 million shares issued as consideration shares, accounting for 8.74% of the expanded capital. The issue price is 12 RMB, a premium of 63.04% over the previous trading day (15th).
Each share of ysb has a premium of 63.04%, with a total acquisition of 1.035 billion in cash and new shares, fully acquiring "One Drug".
On October 15th, YSB (09885) announced on the HKEX that it has signed a trade agreement to acquire 100% of the shares of the csi health care 100 index, with a total consideration of RMB 1.035 billion, including a cash consideration of 0.42 billion yuan and a share consideration of 0.615 billion yuan. The share consideration part will issue new shares to the original shareholder of the csi health care 100 index at HKD 12 per share, with a premium of 63.04% over the closing price on the day of the signing of the acquisition agreement. This acquisition is a key step for YSB to deepen its industry layout, further enhancing its market competitiveness and profitability. The csi health care 100 index was established in 2019 and is a leading domestic
ysb (09885) intends to acquire Folding Space (Cayman) Ltd. with 1.035 billion yuan for 100% of the issued and outstanding share capital.
ysb (09885) issued an announcement, on October 15, 2024 (after the trading hours of the Stock Exchange), the company,...
YSB: 2024 Interim Report
Stock Connect market share abnormal statistics | September 9th
Statistics on the proportion of individual Hong Kong stock through the smart connect | September 6, 2024.
Pharmacist Help (09885) issued 1 million shares due to the exercise of stock rights.
Yao Shi Bang (09885) announced that, according to the share incentive plan adopted by the company on January 1, 2019...
As the profit potential gradually opens up, what did the pharmacist assistant (09885) do right?
On August 26, Pharmacist Help (09885) announced its latest semi-annual performance, not only achieving double-digit revenue growth, but also turning a profit for the first time. Net income exceeded 13 million yuan, turning positive for the first time from a significant loss.
Net income turning positive for the first time, how should we view Yaoshi Bang (09885.HK) going forward?
With the approaching of the Federal Reserve's interest rate cut window, highly interest rate-sensitive industries such as pharmaceuticals are having a positive market outlook. Many authoritative institutions have spoken out, pointing out that pharmaceutical stocks, due to their sensitive response to interest rate changes, are highly likely to stand out and become the darlings of the capital markets under the catalyst of interest rate cuts. Among them, many stocks with both cost-effectiveness and excellent potential are quietly nurturing rich investment opportunities, waiting for investors to discover. Recently, Pharmacist Help, China's largest digital comprehensive service platform for out-of-hospital pharmaceutical industry, released the performance data for the first half of 2024, with the company's revenue continuing to maintain double-digit growth.
Pharmacist (9885.HK) released interim results: revenue increased by 10.6% year-on-year, and net income increased by 30.3% after adjustment.
Pharmacist Assist today released its 2024 mid-term financial performance announcement.
Pharmacist Help (09885.HK) announced its interim performance, with adjusted net income increasing by 30.3%. The number of pharmacist products has exceeded 170.
Pharmacist Help (09885.HK) announced that for the six months ending June 30, 2024, the group achieved a revenue of RMB 88,140,000, an increase of 10.6% year-on-year. The increase in revenue is mainly attributed to the continuous and stable development of self-operated business and platform business during the reporting period. The group's research and development expenses increased by 14.5% from RMB 39.9 million in the same period of the previous year to RMB 45.7 million during the period, mainly due to the increase in equity-settled share-based payment expenses. For the six months ending June 30, 2024, the group's net profit was RMB 13.4 million.
Pharmacist Help (09885) released its interim performance, with adjusted net income of 91.411 million yuan, an increase of 30.3% year-on-year.
Pharmacist Help (09885) released its interim results for the six months ended June 30, 2024, and the group achieved revenue of...
Pharmacist Bank (09885.HK) turned from half-year loss to profit, earning 21.82 million RMB.
Pharmacy (09885.HK) announced its interim performance as of the end of June this year, with revenue of 8.814 billion yuan (same below), a year-on-year increase of 10.6%. It turned losses into profits, earning 21.82 million yuan, compared to a loss of 3.169 billion yuan in the same period last year; earnings per share were 0.03 yuan. No dividend will be distributed. According to non-"International Financial Reporting Standards," adjusted net profit for the first half of the year increased by 30.3% year-on-year to 91.411 million yuan.
YSB: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024
Yao Shi Bang (09885.HK) will hold a board of directors meeting on August 26 to approve the mid-year performance.
Pharmacist Help (09885.HK) announced on August 14th that the company will hold a board of directors meeting on August 26th, 2024, to approve the mid-term performance of the company and its subsidiaries for the six-month period ending June 30, 2024, as well as to consider the proposal of distributing interim dividends (if any).
YSB: NOTICE OF BOARD MEETING
Analysis
Price Target
No Data
No Data